BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24070462)

  • 1. A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
    Marchesi F; Cenfra N; Altomare L; Dessanti ML; Mecarocci S; Cerchiara E; Rago A; D'Andrea M; Tomarchio V; Olimpieri OM; Tirindelli MC; Mengarelli A; Petti MC; Avvisati G; Cimino G
    J Geriatr Oncol; 2013 Jul; 4(3):242-8. PubMed ID: 24070462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment.
    Yoshida M; Nakao T; Horiuchi M; Ueda H; Hagihara K; Kanashima H; Inoue T; Sakamoto E; Hirai M; Koh H; Nakane T; Hino M; Yamane T
    Eur J Haematol; 2016 Apr; 96(4):409-16. PubMed ID: 26084899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
    Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
    Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
    Park S; Hong J; Hwang I; Ahn JY; Cho EY; Park J; Cho EK; Shin DB; Lee JH
    J Geriatr Oncol; 2015 Nov; 6(6):470-8. PubMed ID: 26522808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
    Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
    Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance.
    Horn J; Kleber M; Hieke S; Schmitt-Gräff A; Wäsch R; Engelhardt M
    Ann Hematol; 2012 Oct; 91(10):1579-86. PubMed ID: 22752146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
    Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
    Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
    Ancochea Á; Salar A; García-Pallarols F; Gimeno E; Fernández-Rodriguez C; Sánchez-González B
    Med Clin (Barc); 2015 Jun; 144(12):544-7. PubMed ID: 25110180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients.
    Naito Y; Sasaki H; Takamatsu Y; Kiyomi F; Tamura K
    J Clin Exp Hematop; 2016; 56(1):43-9. PubMed ID: 27334857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: a multicenter experience.
    Ishii K; Urase F; Nagare Y; Kimura H; Manabe M; Yagi T; Teshima H; Hayashi K; Shibano M; Tsukaguchi M; Katsurada T; Mugitani A; Kitayama H; Nomura S
    Arch Gerontol Geriatr; 2010; 51(2):209-15. PubMed ID: 19926148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
    Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
    Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma--possible pitfalls in results reporting and interpretation.
    Jelić S; Milanović N; Tomasević Z; Matković S; Gavrilović D
    Neoplasma; 1999; 46(6):394-9. PubMed ID: 10732870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Curative effect on aggressive B cell non-Hodgkin's lymphoma and relevant influencing factors of its prognosis, a study of 203 cases].
    Xu RH; Jiang WQ; Li YH; Lin TY; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):191-4. PubMed ID: 12812658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
    Allen P
    Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.
    Basso U; Tonti S; Bassi C; Brunello A; Pasetto LM; Scaglione D; Falci C; Beda M; Aversa SM; Stefani M; Castegnaro E; Tamellini F; Monfardini S
    Crit Rev Oncol Hematol; 2008 May; 66(2):163-70. PubMed ID: 18243726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
    Worch J; Rohde M; Burkhardt B
    Pediatr Hematol Oncol; 2013 Sep; 30(6):465-83. PubMed ID: 23570584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of comprehensive geriatric assessment in elder patients with non-Hodgkin's lymphoma].
    Liu H; Gao M; Mei D; Han HX; Li JT; Bai JF; Zhang CL; Feng R; Wei JP; Tian Y; Wang T
    Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):330-334. PubMed ID: 29747287
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
    Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
    Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.